Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06951516 · ClinicalTrials.gov registry record · NA

How Simplified Language Affects Comprehension and Learning in Young Children With Down Syndrome

A NA study of Down Syndrome, sponsored by Michigan State University.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06951516: Recruiting NA study of Down Syndrome, sponsored by Michigan State University.

NCT06951516 is a NA study of Down Syndrome that is actively recruiting participants, run by Michigan State University. The registered enrollment target is 30 participants, below the 2,471-participant average among 54 other Down Syndrome trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06951516, a NA study of Down Syndrome, is actively recruiting participants, sponsored by Michigan State University.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The long-term study goal is to experimentally evaluate the components (and likely active ingredients) of early language interventions for young children with Down syndrome (DS). The overall objective is to determine how single-word and telegraphic simplification affects real-time language processing and word learning in young children with DS (relative to full, grammatical utterances). The proposed project will investigate three specific aims: 1) Determine how single-word and telegraphic simplification affects language processing. 2) Determine how single-word and telegraphic simplification affects word learning. 3) Evaluate child characteristics that may moderate the effects of linguistic simplification on language processing and word learning. Aim 1 will test the hypothesis that children with DS will process grammatical utterances faster and more accurately than telegraphic or single-word utterances. Aim 2 will test the hypothesis that overall, children will demonstrate better word learning in the grammatical compared to the single-word and telegraphic conditions. Aim 3 will test the hypothesis that receptive language and nonverbal cognitive abilities will be significant moderators, such that children with stronger linguistic and cognitive skills will show the greatest benefit from grammatical input but children with lower linguistic and cognitive scores will perform similarly across conditions.

Primary Outcome

LWL involves a child looking at a screen with two images, one on each side of the screen, while being provided an auditory cue that includes the name of the target image. The primary outcome is a dichotomous variable indicating whether the child is fixated on the target image or the distracter image; gaze directed at neither image will be considered missing. It will be determined whether gaze is to the left or right image, using trained coders who are blind to target side. Gaze location will be

Conditions Studied

Interventions

  • BEHAVIORAL Linguistic simplification

Study Locations (1)

Michigan

  • Michigan State University - East Lansing

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2025-01-01
Est. Completion 2027-05-31
Phase NA
Michigan State University

120 total trials

What NCT06951516 shows while recruiting

NCT06951516 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 2,471-participant average among 54 other Down Syndrome trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Down Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Linguistic simplification is the first listed.

NCT06951516 reports a single indexed study location in Michigan.

Frequently Asked Questions

What is clinical trial NCT06951516 about?

NCT06951516 is a clinical study titled "How Simplified Language Affects Comprehension and Learning in Young Children With Down Syndrome". The long-term study goal is to experimentally evaluate the components (and likely active ingredients) of early language interventions for young children with Down syndrome (DS). The overall objective is to determine how single-word and telegraphic simplification affects real-time language processing...

What is the current status of trial NCT06951516?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2025-01-01. Estimated completion is 2027-05-31.

What conditions does trial NCT06951516 study?

This clinical trial studies the following conditions: Down Syndrome.

What interventions are being tested in trial NCT06951516?

The interventions under investigation include: Linguistic simplification (BEHAVIORAL).

Who is sponsoring clinical trial NCT06951516?

This trial is sponsored by Michigan State University, which has 120 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06951516 being conducted?

This trial has 1 study location across Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Down Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06951516's enrollment target sits among peer trials

30 41st of 54 higher than 14 of 54 other Down Syndrome trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Down Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06951516, the US trial registry maintained by the National Library of Medicine. NCT06951516 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.